title: IL2RA/CD25 polymorphisms contribute to multiple sclerosis susceptibility.
authors.forename: Fuencisla
authors.initials: F
authors.lastname: Matesanz
authors.forename: Alfredo
authors.initials: A
authors.lastname: Caro-Maldonado
authors.forename: Maria
authors.initials: M
authors.lastname: Fedetz
authors.forename: Oscar
authors.initials: O
authors.lastname: Fernández
authors.forename: Roger L
authors.initials: RL
authors.lastname: Milne
authors.forename: Miguel
authors.initials: M
authors.lastname: Guerrero
authors.forename: Concepción
authors.initials: C
authors.lastname: Delgado
authors.forename: Antonio
authors.initials: A
authors.lastname: Alcina
mesh_terms: D016022:Case-Control Studies; D016009:Chi-Square Distribution; D004252:DNA Mutational Analysis; D005260:Female; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D053645:Interleukin-2 Receptor alpha Subunit / Q000235:genetics*; D008297:Male; D009103:Multiple Sclerosis / Q000453:epidemiology / Q000235:genetics*; D016017:Odds Ratio; D011110:Polymorphism, Genetic / Q000235:genetics*; D012235:Rhodamines / Q000378:metabolism; D013030:Spain / Q000453:epidemiology; D044465:White People / Q000235:genetics
chemical_list: C508017:IL2RA protein, human; D053645:Interleukin-2 Receptor alpha Subunit; D012235:Rhodamines; C103221:Texas Red-X succinimidyl ester